Evaluation of CD16, CD32, CD40, and CD152 polymorphisms in immune thrombocytopenia patients: a systematic review, meta-analysis, and trial sequential analysis - Top-Institutions - MDSpire

Evaluation of CD16, CD32, CD40, and CD152 polymorphisms in immune thrombocytopenia patients: a systematic review, meta-analysis, and trial sequential analysis

  • By

  • Yan Pan

  • Fangjian Chen

  • Yanzhong Wang

  • June 23, 2026

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Leiden University
    Leiden University

    Leiden, South Holland

    Key Differentiators

    • Hematology

  • #2

    University of Pavia
    University of Pavia

    Pavia, Lombardy

    Key Differentiators

    • Hematology

  • #3

    University of Freiburg
    University of Freiburg

    Freiburg, Baden-Württemberg

    Key Differentiators

    • Hematology

  • #4

    University of Tübingen
    University of Tübingen

    Tübingen, Baden-Württemberg

    Key Differentiators

    • Hematology

  • #5

    University of Perugia
    University of Perugia

    Perugia, Umbria

    Key Differentiators

    • Hematology

Original Source(s)

Evaluation of CD16, CD32, CD40, and CD152 polymorphisms in immune thrombocytopenia patients: a systematic review, meta-analysis, and trial sequential analysis

  • by Yan Pan, Fangjian Chen, Yanzhong Wang

  • June 23, 2026

Related Content

Modulating CAR-T cell exhaustion and fitness in acute myeloid leukemia: mechanistic metabolic and microenvironmental strategies

Case Report: Endovascular treatment of spontaneous iliac vein rupture complicated with lower extremity deep vein thrombosis

Development of a BM7G(TKO/hCD46/hCD55/hTHBD/hEPCR) donor pig with endogenous promoter-driven transgenes for xenotransplantation